会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • NEW BENZOFURAN DERIVATIVES AS SELECTIVE 5HT7 RECEPTOR INHIBITORS AND PROCESS FOR THEIR PREPARATION
    • 作为选择性5HT7受体抑制剂的新型苯佐衍生物及其制备方法
    • WO2008146064A1
    • 2008-12-04
    • PCT/HU2008/000061
    • 2008-05-30
    • EGIS GYÓGYSZERGYÁRPRAUDA, IbolyaRIVÓ, EndreREITER, JózsefBARKÖCZY, JózsefGACSÁLYL, IstvánKOMPAGNE, HajnalkaSZIRAY, NóraPALLAGI, KatalinEGYED, AndrásHEGEDÜS, EndreLÉVAY, GyörgyHÁRSING, László Gábor
    • PRAUDA, IbolyaRIVÓ, EndreREITER, JózsefBARKÖCZY, JózsefGACSÁLYL, IstvánKOMPAGNE, HajnalkaSZIRAY, NóraPALLAGI, KatalinEGYED, AndrásHEGEDÜS, EndreLÉVAY, GyörgyHÁRSING, László Gábor
    • C07D307/86C07D405/12A61K31/4525A61P25/00
    • C07D405/12C07D307/86
    • The present invention relates to new selective 5HT 7 receptor binding benzofuran derivatives of general formula (I), wherein X represents a halogen atom or SO 2 NR 1 R 2 group, wherein R 1 and R 2 represent, independently, a hydrogen atom, C 1-6 alkyl group, C 3-6 cycloalkyl group, phenyl group substituted with one or more halogen atom(s) or 1,7.7-trimethyl-bicyclo[2,2,1]hept-2-yl group, Y represents C 2-6 alkylene group, optionally substituted with hydroxy group, A represents carbon atom, nitrogen atom or CH group, B represents CH or CH 2 group, Q represents C 1-4 alkyl group, a phenyl group optionally substituted with one or more halogen atom(s), C 1-4 alkoxy group or trifluoromethyl group; phenylamino group substituted with a halogen atom or trifluoromethyl group; pyridine heterocycle; benzisoxazole or benzisothiazole heterocycle, optionally substituted with a halogen atom; benzimidazole or benzimidazolone heterocycle, optionally substituted with a halogen atom or trifluoromethyl group on the benzene ring, or optionally substituted on one of the N atoms with an C 1-4 alkyl group; benzodioxane heterocycle, optionally substituted with a halogen atom on the benzene ring; pyridazinone heterocycle substituted with a halogen atom; dibenzothiazepine heterocycle or Q together with groups A and B represents a thiophene ring and their pharmaceutically suitable acid addition salts, with the proviso that if Y represents 2-hydroxy propylene group, A represents a carbon atom, B represents CH group, and Q represents 3-trifluoro-methyl-phenyl group, then X does not represent bromo atom. The invention extends to the process for producing said compounds, to pharmaceutical compositions containing said compounds and to their use in treatment and/or prevention of disorders of the central nervous system and cardiovascular system.
    • 本发明涉及通式(I)的新的选择性5HT7受体结合苯并呋喃衍生物,其中X表示卤素原子或SO2NR1R2基团,其中R1和R2独立地表示氢原子,C1-6烷基,C3-6 环烷基,被一个或多个卤素原子或1,7,7-三甲基 - 双环[2,2,1]庚基取代的苯基,Y表示任选被羟基取代的C 2-6亚烷基 A表示碳原子,氮原子或CH基,B表示CH或CH2基,Q表示C1-4烷基,任选被一个或多个卤素原子取代的苯基,C 1-4烷氧基或三氟甲基 ; 被卤素原子或三氟甲基取代的苯基氨基; 吡啶杂环; 苯并异恶唑或苯并异噻唑杂环,任选被卤素原子取代; 苯并咪唑或苯并咪唑酮杂环,任选被苯环上的卤素原子或三氟甲基取代,或任选地在一个N原子上被C 1-4烷基取代; 苯并二恶烷杂环,任选被苯环上的卤素原子取代; 用卤素原子取代的哒嗪酮杂环; 二苯并硫氮杂环或Q与A和B组一起代表噻吩环及其药学上合适的酸加成盐,条件是如果Y表示2-羟基丙基,则A表示碳原子,B表示CH基,Q表示3 三氟甲基 - 苯基,则X不表示溴原子。 本发明涉及生产所述化合物的方法,含有所述化合物的药物组合物及其在治疗和/或预防中枢神经系统和心血管系统疾病中的用途。